Larvol Delta - Evaluation-of-the-Safety-Tolerability-and-Efficacy-of-MDGN002-in-Adults-With-Moderate-to-Severe-Active-Crohn39s-Disease-or-Ulcerative-Colitis

AVTX-002 - Kyowa Kirin, Sanofi, Avalo Therap

http://clinicaltrials.gov/ct2/show/NCT03169894

Jan 10, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next